Literature DB >> 6273929

Epidermal growth factor-receptor-protein kinase interactions.

S Cohen, G Carpenter, L King.   

Abstract

Membranes prepared from A-431 human epidermoid carcinoma cells retained the ability to bind 125I-labeled epidermal growth factor (EGF) in a specific manner. In the presence of [gamma-32]ATP and Mn2+ or Mg2+, this membrane preparation was capable of phosphorylating specific endogenous membrane proteins, as well as exogenously added histone. The binding of EGF to membranes in vitro resulted in a several-fold stimulation of the phosphorylation reaction. The phosphorylation reaction was not dependent on cyclic AMP or cyclic GMP. These findings suggest that one of the biochemical consequences of the binding of EGF to membranes is a rapid activation of a cyclic AMP-independent phosphorylating system. The activation of the membrane-associated protein kinase by EGF appears to be a reversible phenomenon. The membrane preparation could be solubilized by a number of non-ionic detergents with the retention of both 125I-labeled EGF binding activity and EGF-enhanced phosphorylation of specific membrane proteins. The solubilized membrane preparation was purified by affinity chromatography. The purified preparation retained both EGF-binding activity and EGF-enhanced phosphorylation activity. Analysis of the affinity-purified preparation by SDS gel electrophoresis indicated the presence of one major protein band of molecular weight 150,000 and several trace bands. The evidence suggests that the major 150,000 protein band is the receptor for EGF and is a substrate of the phosphorylation reaction. The co-purification of EGF-binding activity and EGF-stimulated phosphorylation activity suggests an inherent close relationship. The EGF-stimulated phosphorylation reaction appears to be specific for tyrosine residues and in this regard resembles the src protein kinase.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6273929

Source DB:  PubMed          Journal:  Prog Clin Biol Res        ISSN: 0361-7742


  8 in total

Review 1.  Epidermal growth factor receptor in non-small cell lung cancer.

Authors:  Charles N Prabhakar
Journal:  Transl Lung Cancer Res       Date:  2015-04

Review 2.  Landscape of EGFR signaling network in human cancers: biology and therapeutic response in relation to receptor subcellular locations.

Authors:  Woody Han; Hui-Wen Lo
Journal:  Cancer Lett       Date:  2012-01-17       Impact factor: 8.679

Review 3.  Current targeted therapies in the treatment of advanced colorectal cancer: a review.

Authors:  Andrew Moriarity; Jacintha O'Sullivan; John Kennedy; Brian Mehigan; Paul McCormick
Journal:  Ther Adv Med Oncol       Date:  2016-05-29       Impact factor: 8.168

Review 4.  Role of epidermal growth factor receptor in lung cancer and targeted therapies.

Authors:  Tie-Cheng Liu; Xin Jin; Yan Wang; Ke Wang
Journal:  Am J Cancer Res       Date:  2017-02-01       Impact factor: 6.166

5.  STAT1 gene expression is enhanced by nuclear EGFR and HER2 via cooperation with STAT3.

Authors:  Woody Han; Richard L Carpenter; Xinyu Cao; Hui-Wen Lo
Journal:  Mol Carcinog       Date:  2012-06-12       Impact factor: 4.784

6.  EGFR and HER2 signaling in breast cancer brain metastasis.

Authors:  Sherona R Sirkisoon; Richard L Carpenter; Tadas Rimkus; Lance Miller; Linda Metheny-Barlow; Hui-Wen Lo
Journal:  Front Biosci (Elite Ed)       Date:  2016-01-01

7.  Coexpression of epidermal growth factor receptor with related factors is associated with a poor prognosis in non-small-cell lung cancer.

Authors:  D E B Swinson; G Cox; K J O'Byrne
Journal:  Br J Cancer       Date:  2004-10-04       Impact factor: 7.640

8.  mTOR regulates proteasomal degradation and Dp1/E2F1- mediated transcription of KPNA2 in lung cancer cells.

Authors:  Chun-I Wang; Yan-Yu Chen; Chih-Liang Wang; Jau-Song Yu; Yu-Sun Chang; Chia-Jung Yu
Journal:  Oncotarget       Date:  2016-05-03
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.